RaySearch Laboratories AB (publ) (FRA:27R)

Market Cap	768.53M
Revenue (ttm)	112.16M
Net Income (ttm)	17.28M
Shares Out	n/a
EPS (ttm)	0.50
PE Ratio	44.48
Forward PE	35.21
Dividend	0.28 (1.22%)
Ex-Dividend Date	May 23, 2025

Volume	n/a
Average Volume	15
Open	22.25
Previous Close	22.40
Day's Range	22.25 - 22.25
52-Week Range	12.96 - 32.70
Beta	n/a
RSI	37.31
Earnings Date	Nov 7, 2025

About RaySearch Laboratories AB

RaySearch Laboratories AB (publ), a medical technology company, provides software solutions for cancer treatment worldwide. The company offers RayStation, a treatment planning system for cancer centers; RayCare, an oncology information system for clinics; RayIntelligence, cloud-based oncology analytics system that cancer centers can use to gather, structure and analyze data; and RayCommand, a treatment control system designed to link the treatment machine and the treatment planning and oncology information systems. It also provides µ-RayStation...

• Industry: Prepackaged Software
• Founded: 2000
• Employees: 416
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 27R

Financial Performance

In 2024, RaySearch Laboratories AB's revenue was 1.19 billion, an increase of 16.62% compared to the previous year's 1.02 billion. Earnings were 203.51 million, an increase of 149.49%.

Financial numbers in SEK